Companion animals: Translational scientist’s new best friends

Author:

Kol Amir1,Arzi Boaz2,Athanasiou Kyriacos A.34,Farmer Diana L.5,Nolta Jan A.67,Rebhun Robert B.2,Chen Xinbin27,Griffiths Leigh G.8,Verstraete Frank J. M.2,Murphy Christopher J.29,Borjesson Dori L.1

Affiliation:

1. Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA.

2. Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA.

3. Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, U.S.A.

4. Department of Orthopedic Surgery, School of Medicine, University of California, Davis, Davis, CA 95616, USA.

5. Department of Surgery, School of Medicine, University of California, Davis, Davis, CA 95616, USA.

6. Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, Davis, CA 95616, USA.

7. Department of Internal Medicine, School of Medicine, University of California, Davis, Davis, CA 95616, USA.

8. Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA.

9. Department of Ophthalmology and Vision Science, School of Medicine, University of California, Davis, Davis, CA 95616, USA.

Abstract

Naturally occurring diseases in companion animals represent an underused resource that holds promise for providing predictive proof of efficacy in the evaluation of new therapeutics and devices.

Funder

NIH

CIRM

ARCS Foundation

UC Davis School of Veterinary Medicine

Winn Foundation

U.C. Davis Stem Cells

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference65 articles.

1. Can Animal Models of Disease Reliably Inform Human Studies?

2. Comparison of the transcriptional landscapes between human and mouse tissues

3. Clinical development success rates for investigational drugs

4. Code of Federal Regulations - Title 21 - Food and Drugs. 312.23 (a)(8) (2015). www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=312.23.

5. Guidance for industry: Preclinical assessment of investigational cellular and gene therapy products (FDA Center for Biologics Evaluation and Research Washington DC 2013).

Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3